You just read:

SHIONOGI ANNOUNCES ACCEPTANCE OF NEW DRUG APPLICATION IN THE U.S. FOR NALDEMEDINE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION

News provided by

Shionogi

Jun 06, 2016, 08:13 ET